SynthesisPharmacoEconomics2018

Systematic Review of Validity Assessments of Framingham Risk Score Results in Health Economic Modelling of Lipid-Modifying Therapies in Europe.

Jonas Hermansson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.